STERIS Management

Management criteria checks 3/4

STERIS' CEO is Dan Carestio, appointed in Jul 2021, has a tenure of 1.5 years. total yearly compensation is $5.90M, comprised of 13% salary and 87% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth €7.13M. The average tenure of the management team and the board of directors is 3 years and 7.2 years respectively.

Key information

Dan Carestio

Chief executive officer

US$5.9m

Total compensation

CEO salary percentage	13.0%
CEO tenure	1.5yrs
CEO ownership	0.04%
Management average tenure	3yrs
Board average tenure	7.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan Carestio's remuneration changed compared to STERIS's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2022	n/a	n/a	-US$8m
Jun 30 2022	n/a	n/a	US$377m
Mar 31 2022	US$6m	US$767k	US$244m
Dec 31 2021	n/a	n/a	US$279m
Sep 30 2021	n/a	n/a	US$250m
Jun 30 2021	n/a	n/a	US$286m
Mar 31 2021	US$3m	US$542k	US$397m
Dec 31 2020	n/a	n/a	US$433m
Sep 30 2020	n/a	n/a	US$424m
Jun 30 2020	n/a	n/a	US$413m
Mar 31 2020	US$2m	US$522k	US$408m
Dec 31 2019	n/a	n/a	US$393m
Sep 30 2019	n/a	n/a	US$336m
Jun 30 2019	n/a	n/a	US$319m
Mar 31 2019	US$2m	US$482k	US$304m
Dec 31 2018	n/a	n/a	US$269m
Sep 30 2018	n/a	n/a	US$316m
Jun 30 2018	n/a	n/a	US$303m
Mar 31 2018	US$1m	US$379k	US$291m
Dec 31 2017	n/a	n/a	US$243m
Sep 30 2017	n/a	n/a	US$144m
Jun 30 2017	n/a	n/a	US$120m
Mar 31 2017	US$1m	US$348k	US$110m
Dec 31 2016	n/a	n/a	US$142m
Sep 30 2016	n/a	n/a	US$167m
Jun 30 2016	n/a	n/a	US$135m
Mar 31 2016	US$2m	US$319k	US$111m

Compensation vs Market: Dan's total compensation ($USD5.90M) is about average for companies of similar size in the German market ($USD4.73M).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.

CEO

Dan Carestio (49 yo)

1.5yrs

Tenure

US$5,903,168

Compensation

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Daniel Carestio	President	1.5yrs	US$5.90m	0.040% $ 7.1m
Michael Tokich	Senior VP & CFO	14.8yrs	US$3.26m	0.043% $ 7.7m
John Zangerle	Senior VP	9.5yrs	US$2.53m	0.028% $ 5.0m
Walter Rosebrough	CEO Emeritus & Senior Advisor	1.5yrs	US$1.16m	0.027% $ 4.9m
Cary Majors	Senior Vice President of Americas Commercial Operations	3.4yrs	US$1.77m	0.013% $ 2.3m
Andrew Xilas	Senior VP & GM of Dental	1.6yrs	US$1.92m	0.0047% $ 850.6k
Karen Burton	Chief Accounting Officer	14.7yrs	no data	0.0060% $ 1.1m
Julie Winter	Vice President of Investor Relations & Corporate Communications	no data	no data	no data
Mary Fraser	VP & Chief Human Resources Officer	2.5yrs	no data	0.0073% $ 1.3m
Julia Madsen	Senior Vice President of Life Sciences	2.5yrs	no data	0.0073% $ 1.3m
Renato Tamaro	VP & Corporate Treasurer	5.4yrs	no data	0.0061% $ 1.1m

3.0yrs

Average Tenure

53.5yo

Average Age

Experienced Management: 2TG's management team is considered experienced (3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Daniel Carestio	President	2yrs	US$5.90m	0.040% $ 7.1m
Richard Breeden	Independent Director	14.8yrs	US$146.54k	0.038% $ 6.9m
Mohsen Sohi	Independent Chairman of the Board	17.5yrs	US$286.48k	0.022% $ 4.0m
Jacqueline Kosecoff	Independent Director	19.3yrs	US$113.53k	0.027% $ 4.8m
Cynthia Feldmann	Independent Director	17.8yrs	US$217.94k	0.0094% $ 1.7m
Richard Steeves	Independent Director	7.2yrs	US$217.95k	0% $ 0
Paul Martin	Independent Director	1.7yrs	US$95.50k	0% $ 0
Nirav Shah	Independent Director	4.7yrs	US$313.30k	0.00029% $ 52.2k
Christopher Holland	Independent Director	2.5yrs	US$105.50k	0.000070% $ 12.6k

7.2yrs

Average Tenure

63yo

Average Age

Experienced Board: 2TG's board of directors are considered experienced (7.2 years average tenure).

STERIS Management

Management criteria checks 3/4

Key information

Recent management updates

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc, Annual General Meeting, Jul 27, 2023

STERIS plc, Annual General Meeting, Jul 28, 2022

Insider recently sold €398k worth of stock

Insider recently sold €2.0m worth of stock

STERIS Announces Leadership Succession Plan

Recent updates

STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024

STERIS plc to Report Q4, 2024 Results on May 08, 2024

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc to Report Q1, 2024 Results on Aug 01, 2023

STERIS plc, Annual General Meeting, Jul 27, 2023

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023

STERIS plc to Report Q3, 2023 Results on Feb 08, 2023

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

STERIS plc to Report Q2, 2023 Results on Nov 09, 2022

Upcoming dividend of US$0.47 per share

First quarter 2023 earnings released: EPS: US$1.11 (vs US$0.24 loss in 1Q 2022)

STERIS plc Provides Revenue Guidance for Fiscal 2023

Steris plc Declares Quarterly Interim Dividend, Payable on September 23, 2022

STERIS plc to Report Q1, 2023 Results on Aug 02, 2022

STERIS plc(NYSE:STE) dropped from Russell 1000 Growth-Defensive Index

STERIS plc, Annual General Meeting, Jul 28, 2022

Upcoming dividend of US$0.43 per share

Full year 2022 earnings released: EPS: US$2.50 (vs US$4.66 in FY 2021)

STERIS plc Provides Earnings Guidance for Fiscal 2023

Steris plc Declares Quarterly Interim Dividend, Payable on June 28, 2022

STERIS plc to Report Q4, 2022 Results on May 11, 2022

Upcoming dividend of US$0.43 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

STERIS plc Raises Earnings Guidance for the Fiscal Year 2022

STERIS plc Declares Quarterly Interim Dividend, Payable March 24, 2022

Insider recently sold €398k worth of stock

Upcoming dividend of US$0.43 per share

Second quarter 2022 earnings released: EPS US$0.70 (vs US$1.24 in 2Q 2021)

Upcoming dividend of US$0.43 per share

Insider recently sold €2.0m worth of stock

STERIS plc Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: US$0.24 loss per share (vs US$1.04 profit in 1Q 2021)

Independent Director David Lewis has left the company

STERIS plc (NYSE:STE) completed the acquisition of Cantel Medical Corp. (NYSE:CMD) from Charles M. Diker, Mark N. Diker, Diker Management LLC, Champlain Investment Partners, LLC, Brown Capital Management, LLC and others.

Full year 2021 earnings released: EPS US$4.66 (vs US$4.81 in FY 2020)

STERIS plc Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022

STERIS plc Provides Earnings Guidance for the Fiscal 2021

New 90-day low: €147

STERIS Announces Leadership Succession Plan

Third quarter 2021 earnings released: EPS US$1.34 (vs US$1.24 in 3Q 2020)

Revenue beats expectations

STERIS plc (NYSE:STE) signed a definitive agreement to acquire Cantel Medical Corp. (NYSE:CMD) for $3.6 billion.

STERIS plc to Report Q3, 2021 Results on Feb 02, 2021

CEO, President & Director recently sold €1.5m worth of stock

Revenue beats expectations

Second quarter 2021 earnings released: EPS US$1.24

STERIS plc to Report Q2, 2021 Results on Nov 02, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age